This study investigated the effects of vitamin D supplementation on key inflammatory and oxidative stress biomarkers in MS patients, revealing a marked decrease in the inflammatory protein CHI3L1 and oxidative stress markers (MDA, TOS), alongside increases in TAC and enzymatic activity (SOD, CAT, GPx) following an 8‐week intervention. Here, CHI3L1 is linked to myeloid sarcoma.